Human CD4 + T cells specific for dominant epitopes of SARS‐CoV‐2 Spike and Nucleocapsid proteins with therapeutic potential

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

(2021) Romina Libster et al.   NEW ENGLAND JOURNAL OF MEDICINE

Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

(2021) Michael J. Joyner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rapid GMP-Compliant Expansion of SARS-CoV-2–Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19

(2021) Rachel S. Cooper et al.   Frontiers in Immunology

SARS-CoV-2 evolution during treatment of chronic infection

(2021) Steven A. Kemp et al.   NATURE

Upregulation of CCR4 in activated CD8 + T cells indicates enhanced lung homing in patients with severe acute SARS‐CoV‐2 infection

(2021) Silvia Spoerl et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2

(2021) Jun Siong Low et al.   SCIENCE

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

(2020) Alba Grifoni et al.   CELL

Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19

(2020) Irani Thevarajan et al.   NATURE MEDICINE

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

(2020) Julian Braun et al.   NATURE

Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19

(2020) Benjamin J. Meckiff et al.   CELL

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

(2020) Yanchun Peng et al.   NATURE IMMUNOLOGY

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

(2020) Annika Nelde et al.   NATURE IMMUNOLOGY

SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein

(2020) Michael D. Keller et al.   BLOOD

Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19

(2020) Petra Bacher et al.   IMMUNITY

SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors

(2020) Alina S. Shomuradova et al.   IMMUNITY

Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19

(2020) Jenny Meinhardt et al.   NATURE NEUROSCIENCE

Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report

(2020) Matthew S. Buckland et al.   Nature Communications

Regulation of Adaptive Immunity; The Role of Interleukin-10

(2013) T. H. Sky Ng et al.   Frontiers in Immunology